|
Global X MSCI China Health Care ETF | CHIH | Global X Telemedicine & Digital Health ETF | EDOC | Invesco S&P 500® Low Volatility ETF | SPLV | Ecolab Inc | ECL | Global X Video Games & Esports ETF | HERO | Dreyfus Institutional Preferred Government Plus Money Market Fund | DPFXX | AdvisorShares Pure US Cannabis ETF | MSOS | American Conservative Values ETF | ACVF | Amplify Inflation Fighter ETF | IWIN | Spear Alpha ETF | SPRX |
Gross Expense Ratio*
0.65%
SEC 30 Day Yield (as of 08/31/23 )
0.66%
Ann. Dividend/Yield
$0.0909/0.65%
Ex-Dividend Date
6/29/2023
52-Wk Range
12.54 - 20.00
Fund Inception
12/07/2018
|
 Loading...
The chart is currently unavailable.
|
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI China Health Care 10/50 Index.The fund invests at least 80% of its total assets in the securities of the underlying index and in ADRs and GDRs based on the securities in the underlying index. The underlying index tracks the performance of companies in the MSCI China Index (the "parent index") that are classified in the health care sector, as defined by the index provider. The fund is non-diversified.
|
Market Return % (as of 08/31/2023) |
NAV Return % (as of 08/31/2023) |
Market Return % (as of 06/30/2023) |
NAV Return % (as of 06/30/2023) |
1-Month |
-7.70% |
-7.74% |
-6.14% |
-6.05% |
3-Month |
-7.44% |
-7.26% |
-11.79% |
-12.21% |
6-Month |
-16.16% |
-16.68% |
-14.91% |
-15.99% |
Year-to-date |
-16.09% |
-17.07% |
-14.91% |
-15.99% |
1-Year |
-11.80% |
-12.17% |
-19.52% |
-18.87% |
3-Year |
-17.53% |
-17.58% |
-15.59% |
-15.44% |
5-Year |
-- |
-- |
-- |
-- |
10-Year |
-- |
-- |
-- |
-- |
Since Inception |
-1.18% |
-1.38% |
-0.92% |
-1.15% |
Inception Date: December 07, 2018
Performance Details
Total return reflects performance without adjusting for sales charges or the effects of taxation, but is adjusted to reflect all actual ongoing fund expenses and assumes reinvestment of dividends and capital gains. If adjusted, sales charges would reduce the performance quoted. Performance data quoted represents past performance, is no guarantee of future results, and may not provide an adequate basis for evaluating the performance potential of the product over varying market conditions or economic cycles. Current performance may be higher or lower than the performance data quotes. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost.
|
Market Return % (as of 08/31/2023) |
NAV Return % (as of 08/31/2023) |
Market Return % (as of 06/30/2023) |
NAV Return % (as of 06/30/2023) |
1-Year |
-11.80% |
-12.17% |
-19.52% |
-18.87% |
5-Year |
-- |
-- |
-- |
-- |
10-Year |
-- |
-- |
-- |
-- |
Since Inception |
-1.18% |
-1.38% |
-0.92% |
-1.15% |
Inception Date: December 07, 2018
0.32% |
0.00% |
0.00% |
0.00% |
0.32% |
0.00% |
0.00% |
0.00% |
0.00% |
99.68% |
99.68% |
0.00% |
Sensitive |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Portfolio Details
|
Company |
YTD Return (as of 09/28/2023) |
% of Assets |
* WuXi Biologics (Cayman) Inc |
-21.26% |
10.71% |
* BeiGene Ltd Ordinary Shares |
-- |
9.51% |
* CSPC Pharmaceutical Group Ltd |
-23.91% |
6.23% |
* Innovent Biologics Inc |
+16.69% |
4.75% |
* Wuxi AppTec Co Ltd |
-- |
3.87% |
* Sino Biopharmaceutical Ltd |
-41.88% |
3.80% |
* Sinopharm Group Co Ltd |
+15.51% |
3.79% |
Legend Biotech Corp ADR |
+34.84% |
3.41% |
Genscript Biotech Corp Class H |
-10.95% |
2.74% |
* Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A |
-- |
2.69% |
* represents an International company or one without a recognizable symbol.
Portfolio Details
|
|
|